T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$2.16B |
| 2 |
GE Aerospace
GE
|
+$1.93B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.62B |
| 4 |
Eli Lilly
LLY
|
+$1.59B |
| 5 |
SPLK
Splunk Inc
SPLK
|
+$1.38B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$2.72B |
| 2 |
Booking.com
BKNG
|
+$2.61B |
| 3 |
RHT
Red Hat Inc
RHT
|
+$1.62B |
| 4 |
JPMorgan Chase
JPM
|
+$1.43B |
| 5 |
State Street
STT
|
+$1.29B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.46% |
| 2 | Technology | 17.53% |
| 3 | Financials | 14.18% |
| 4 | Consumer Discretionary | 14.02% |
| 5 | Communication Services | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JMP
1426
DELISTED
JMP Group LLC
JMP
| $3.96M | ﹤0.01% |
1,014,112
| – | – |
|
1427
Reinsurance Group of America
RGA
$16.4B
| $3.88M | ﹤0.01% |
27,694
+3,954
| +17% | +$560K |
|
1428
SiriusXM
SIRI
$9.43B
| $3.86M | ﹤0.01% |
67,660
+11,814
| +21% | +$718K |
|
|
P
1429
DELISTED
Pandora Media Inc
P
| $3.84M | ﹤0.01% |
474,456
-185,738
| -28% | -$1.6M |
|
|
QVCGA
1430
DELISTED
QVC Group Inc Series A
QVCGA
| $3.83M | ﹤0.01% |
4,043
-78
| -2% | -$82K |
|
1431
Arch Capital
ACGL
$33.5B
| $3.75M | ﹤0.01% |
140,255
-4,271
| -3% | -$118K |
|
1432
National Healthcare
NHC
$3.44B
| $3.74M | ﹤0.01% |
47,663
+22
| +0% | +$1.72K |
|
1433
Herbalife
HLF
$1.28B
| $3.72M | ﹤0.01% |
63,094
+154
| +0.2% | +$8.5K |
|
|
HZN
1434
DELISTED
Horizon Global Corporation
HZN
| $3.69M | ﹤0.01% |
2,583,677
-2,820
| -0.1% | -$11K |
|
|
ESV
1435
DELISTED
Ensco Rowan plc
ESV
| $3.61M | ﹤0.01% |
253,221
| – | – |
|
1436
AGNC Investment
AGNC
$13B
| $3.6M | ﹤0.01% |
205,460
+43,577
| +27% | +$776K |
|
1437
AC Immune
ACIU
$262M
| $3.58M | ﹤0.01% |
378,700
-700
| -0.2% | -$6.61K |
|
1438
Hudbay
HBM
$11.8B
| $3.56M | ﹤0.01% |
753,749
-142,569
| -16% | -$670K |
|
1439
nLIGHT
LASR
$2.9B
| $3.56M | ﹤0.01% |
+200,342
| New | +$3.79M |
|
|
DRNA
1440
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $3.56M | ﹤0.01% |
+332,615
| New | +$4.37M |
|
1441
iQIYI
IQ
$1.31B
| $3.55M | ﹤0.01% |
+238,919
| New | +$4.99M |
|
1442
Ingredion
INGR
$6.63B
| $3.54M | ﹤0.01% |
38,745
+827
| +2% | +$82.8K |
|
1443
Autoliv
ALV
$8.89B
| $3.53M | ﹤0.01% |
50,313
+6,445
| +15% | +$523K |
|
1444
Ares Capital
ARCC
$14.5B
| $3.51M | ﹤0.01% |
225,000
| – | – |
|
|
KA
1445
DELISTED
Kineta, Inc. Common Stock
KA
| $3.46M | ﹤0.01% |
7,636
+6,670
| +690% | +$4.52M |
|
|
AYX
1446
DELISTED
Alteryx Inc
AYX
| $3.44M | ﹤0.01% |
57,843
-190,612
| -77% | -$10.4M |
|
1447
Toronto Dominion Bank
TD
$203B
| $3.43M | ﹤0.01% |
69,037
+4,294
| +7% | +$235K |
|
1448
Dell
DELL
$320B
| $3.39M | ﹤0.01% |
136,778
-240,188
| -64% | -$6.58M |
|
1449
Meritage Homes
MTH
$4.8B
| $3.36M | ﹤0.01% |
183,066
+170
| +0.1% | +$3.14K |
|
|
WDR
1450
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $3.36M | ﹤0.01% |
185,708
-992,836
| -84% | -$19.3M |
|
Similar funds
T. Rowe Price Associates's Q4 2018 Portfolio in Review
As of Q4 2018, T. Rowe Price Associates held 2,656 positions worth $591B, down 14% from $685B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
T. Rowe Price Associates's Q4 2018 filing shows 75 new, 1,551 increased, 819 reduced and 97 closed positions. Its largest new stake was StoneCo: 28,883,228 shares worth $519M. The largest sale was Tesla, an estimated $2.72B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Financials.
- T. Rowe Price Associates's largest Q4 2018 buy was StoneCo: 28,883,228 shares worth $519M.
- T. Rowe Price Associates added most to Meta Platforms (Facebook) in Q4 2018, an estimated $2.16B increase.
- T. Rowe Price Associates's biggest Q4 2018 reduction was Tesla, cutting an estimated $2.72B.
- T. Rowe Price Associates fully exited Aetna Inc in Q4 2018, selling an estimated $600M.
- T. Rowe Price Associates's ten largest holdings make up 20% of its $591B portfolio in Q4 2018.
- T. Rowe Price Associates opened 75 new positions and closed 97 in Q4 2018.
- T. Rowe Price Associates's portfolio value fell 14% quarter-over-quarter to $591B.
Based on T. Rowe Price Associates's 13F filing for Q4 2018, filed 14 Feb 2019.